how many americans are using glp 1 People Take GLP-1 Medications in the US DPAC
Description
Bring concise, actionable insights from TRC experts straight to your ears
Growth is supported by expanding domestic peptide manufacturing capabilities, increasing government initiatives targeting metabolic diseases, and improving access to innovative obesity therapies
Caffeine & stimulants: Commonly found in weight-loss products, these ingredients can lead to agitation, hyperactivity, tremors or seizures, and abnormal heart rhythms when ingested
The main limitations of our study include a significant heterogeneity in terms of study design, patient populations, GLP-1 RA dosage regimens, and duration of follow-up
EWG estimates nearly 30,000 industrial sites in the U.S
